I am currently the CEO of ZIOPHARM Oncology, a cancer drug development biotech company based out of New York and Boston. One of the lead drugs we are developing (Zymafos / Palifosfamide) is being developed in soft tissue sarcoma. This is a small molecule that works in a similar way to ifosfamide, with hopefully better…